CRC

我们是谁

• 1 月 5, 2024

  Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

• 4 月 5, 2022

  HLX208（BRAF V600E 抑制剂）联合西妥昔单抗治疗一线治疗后出现 BRAF V600E 突变的转移性结直肠癌 (mCRC) 的疗效观察

• 1 月 1, 1970

  Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM